バイオファーマ創薬・開発：ワールドワイド細胞ベース・スクリーニング＆解析市場の動向と展望

Abstract

Executive Summary

This report reviews, analyzes and sizes the cell based screening and analysis market. The study uncovers interesting information about key equipment, consumables, reagents, software and services that are marketed to biotech and pharmaceutical companies that are doing drug discovery research.

Large bio-pharma companies have commented at industry meetings that fifty percent of their high throughput compound screening projects in drug discovery involves screening cells. The companies are using cell-based assays for both primary and secondary screening and have taken a great interest in the areas of high content screening and high content analysis.

The report assesses the market and maps the competitors on the market landscape with more than 80 companies identified. The financial section sizes the market and discusses the five-year revenue projection. The market is segmented by major product areas as well as market sub segments. This market is also segmented by major world regions to see the growth or how the market share might change.

Major company alliances, M&As, patents that were issued during the last two years are reviewed and analyzed. Large data tables summarize the alliances, M&As and patents. The alliance table summarizes more than 210 deals. The patent table displays key details of over 340 patents. This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. More than 42 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like.

This report includes 28 company profiles that provide the reader a snapshot of the companies- focus or activities. The provided Internet links help readers access companies' own web sites for further review.

Table of Contents

1. What Cell Analysis is and What We Are Aiming for With This Research Project

• 1.1 Our Definition of the Cell Analysis Market
• 1.2 The Aim of This Research Report

2. Overview-- Current Market Status and R&D Status in Biotech and Pharma (Bio-Pharma) for Cell Analysis

• 2.1 Cell Based Screening & Analysis Helps Pharma Productivity
  • 2.1.1 Drug Making Productivity
  • 2.1.2 Increasing Use of Cell Based Screening and Analysis Platforms
• 2.2 Cell-Based Analysis Applications in Bio-Pharma Drug Discovery & Development
  • 2.2.1 Traditional Pharma Drug Discovery Paradigm & Compound Screening
  • 2.2.2 Drug Targets and Main Drug Target Classes
  • 2.2.3 Cell Assay Development - Bio-pharmas Make Their Own Assays
  • 2.2.4 High Throughput Screening (HTS) & High Content Screening (HCS)
  • 2.2.5 Toxicology Testing (Safety Screening)
• 2.3 Current Equipment & Tools and R&D for Cell Analysis
• 2.4 Current Technologies and Related R&D for Cell Based Screening-Analysis
• 2.5 Current Reagents & Assays and Related R&D for Cell Based Screening-Analysis
• 2.6 Main Competitors by Large, Medium and Start-up (Emerging Companies)

3. Trends and Directions of Cell Based Screening and Analysis Equipment and Technologies

• 3.1 Trends: Cell Screening Equipment
  • 3.1.1 Plate Imaging Equipment for Cell based HTS
  • 3.1.2 Imaging Cytometry Equipment for HCS/ HCA
  • 3.1.3 Emerging Developments In Cell Based Screening
• 3.2 Trends: Cell Screening Technologies
  • 3.2.1 Labeling Reagents and No-Wash Assays
  • 3.2.2 Cells as Reagents
  • 3.2.3 Stem Cells Used as a Drug Discovery Tool

4. Alliances & IP

• 4.1 Summary and Review of Major M&As, Alliances, or Deals
  • 4.1.1 M&A and Alliances at a Glance
  • 4.1.2 Leading M&A Acquirers
  • 4.1.3 Data Tables for M&As and Alliances Involving Cell-Based Analysis
• 4.2 Summary of Key Patent IP Involving Cell-Based Analysis

5. Market Size and Forecast 2006 to 2010

• 5.1 The Total Worldwide Cell-Based Screening-Analysis Market Size
• 5.2 Market Segments by Product Type and Revenues
  • 5.2.1 Major Market Segments by Main Product Areas
  • 5.2.2 Comparison of Major Market Segments by Market Shares, 2006 & 2010
  • 5.2.3 Equipment Segment by Product Type
  • 5.2.4 ' Consumables' Segment by Product Type
  • 5.2.5 Content Segment by Product Type
  • 5.2.6 Services Segment by Product Type
  • 5.2.7 ' Others' Segment by Product Type
• 5.3 Market Segments By Major Worldwide Regions
  • 5.3.1 Region Segments
  • 5.3.2 Comparison of Region Segments by Market Shares, 2006 & 2010
• 5.4 Outlook for Leading Commercial Vendors Market Share Rank

6. Activities of Cell Based Screening-Analysis Companies

• 6.1 Multiplatform Cell Screening/Analysis Systems
  • 6.1.1 to 6.1.7 Total 7 companies
• 6.2 Flow Cytometry Screening Systems
  • 6.2.1 to 6.2.4 Total 4 companies
• 6.3 High Content Screening/Analysis Cell Imaging Systems
  • 6.3.1 to 6.3.5 Total 5 companies
• 6.4 Cell-Based Screening Assays/Reagents
  • 6.4.1 to 6.4.5 Total 5 companies
• 6.5 Cell Screening Assays/Reagents
  • 6.5.1 to 6.5.3 Total 3 companies
• 6.6 Contract Research and Development Services
  • 6.6.1 to 6.6.3 Total 3 companies
• 6.7 Cell Screening/Analysis Software
  • 6.7.1 to 6.7.4 Total 4 companies

7. Conclusions: Findings & Opportunities

• 7.1 Important Findings
  • 7.1.1 Market Size and Growth
  • 7.1.2 Alliances and IP
  • 7.1.3 Bio-Pharma Product & Technology Users
  • 7.1.4 Equipment
  • 7.1.5 Services
• 7.2 The Cell-Based Screening & Analysis Business/ Tech Market Roadmap and Opportunities
  • 7.2.1 Major CBSA Products & Services Segments by Growth Rate
  • 7.2.2 Important Growth Areas Within Major Segments

8. Appendix

• 8.1 Company Contacts
• 8.2 Patent Data Tables

• Table 1. Equipment for Cell Based Screening and Analysis
• Table 2. Equipment Competitors by Large, Medium & Small Companies
• Table 3. Consumables Competitors by Large, Medium & Small Companies
• Table 4. Content Competitors by Large, Medium & Small Companies
• Table 5. Services Competitors by Large, Medium & Small Companies
• Table 6. Other Competitors by Large, Medium & Small Companies
• Table 7. Wide Field vs. Confocal HCS/ HCA Equipment
• Table 8. Confocal HCS/ HCA Imaging Equipment Used By Bio-Pharmas
• Table 9. Summary of Cell-based M&As & Alliances, Jan-2004 through Oct-2006
• Table 10. Summary of Cell-based M&As by Top Acquirers
• Table 11. M&As and Alliances, Through Oct. 2006
• Table 12. M&As and Alliances, 2005
• Table 13. M&As and Alliances for Cell-Based Screening and Analysis, 2004
• Table 14. CBA Related IP by No. of New Patents Issued, 2005 & 2006
• Table 15. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.Drug Discovery & Development (BPDD)
• Table 16. WW Market by Major Segments & Revenues
• Table 17. WW Market by Major Segments & Shares, 2006 & 2010
• Table 18. ' Equipment' Segments by Product Type
• Table 19. ' Consumables' Segments by Type
• Table 20. ' Content' Segments by Type
• Table 21. ' Services' Segments by Type
• Table 22. The ' Others' Segment
• Table 23. CBSA Market by Major Worldwide Regions
• Table 24. Market by Major Worldwide Region Share, 2006 & 2010
• Table 25. Leading ' Equipment' Vendors by Est. Market Share Rank
• Table 26. Leading ' Consumables' Vendors by Est. Market Share Rank
• Table 27. Major CBSA Products & Services Segments by Growth Rate
• Table 28. ' Services' Sub-segments by Growth Rate
• Table 29. ' Consumables' Sub-segments by Growth Rate
• Table 30. ' Equipment' Sub-segments by Growth Rate
• Table 31. Company Contacts, Web Links and State/Country
• Table 32. Patent Data by Technology Type, Company, Patent and Title

• Figure 1. WW Cell Based Screening and Analysis by Products & Services
• Figure 2. Traditional Drug Discovery and Development Paradigm
• Figure 3. MDC FLIPR vs. Competing HTS Flash Luminescence Plate Imagers
• Figure 4. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma. Drug Discovery & Development (BPDD)
• Figure 5. WW Market by Major Segments & Revenues
• Figure 6. WW Market by Major Segments & Shares, 2006 & 2010
• Figure 7. ' Equipment' Segments by Type
• Figure 8. ' Consumables' Segments by Type
• Figure 9. ' Content' Segments by Type
• Figure 10. ' Services' Segments by Type
• Figure 11. The ' Others' Segment
• Figure 12. CBSA Market by Major Worldwide Regions
• Figure 13. Market by Major Worldwide Region Share, 2006 & 2010
• Figure 14. A Typical High Content Screening Solution
• Figure 15. Molecular Devices Cell Based Screening Systems
• Figure 16. Cellomics Imaging System for High Content Screening and Analysis